Collectively, Nat10 deficiency reshaped the tumor immune microenvironment by promoting infiltration of effector T cells, enhancing their cytotoxic function, and mitigating their exhaustion, ultimately bolstering antitumor immunity in CRC models. This evidence concerns the gene NAT10 and colorectal carcinoma.